(Q36061335)

11 August 2017

1 reference

title

Diabetic nephropathy: the proteinuria hypothesis (English)

1 reference

11 August 2017

1 reference

Mark E Williams

1

1 reference

11 August 2017

language of work or name

1 reference

3 March 2005

1 reference

American Journal of Nephrology

11 August 2017

published in

1 reference

11 August 2017

volume

25

1 reference

11 August 2017

issue

2

1 reference

11 August 2017

page(s)

77-94

1 reference

Outcome studies in diabetic nephropathy

11 August 2017

cites work

1 reference

21 January 2018

Diabetes and nephropathy

1 reference

Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes

21 January 2018

1 reference

The health care costs of diabetic nephropathy in the United States and the United Kingdom.

21 January 2018

1 reference

Nephropathy in patients with type 2 diabetes mellitus

21 January 2018

1 reference

Albuminuria and renal insufficiency prevalence guides population screening: results from the NHANES III.

21 January 2018

1 reference

Regression of microalbuminuria in type 1 diabetes

21 January 2018

1 reference

Management of glomerular proteinuria: a commentary

21 January 2018

1 reference

Progression of chronic renal failure

21 January 2018

1 reference

Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK)

21 January 2018

1 reference

Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study

21 January 2018

1 reference

Causes and consequences of proteinuria: the kidney filtration barrier and progressive renal failure

21 January 2018

1 reference

Albuminuria and vascular damage--the vicious twins

21 January 2018

1 reference

Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease

21 January 2018

1 reference

C-reactive protein modifies the relationship between blood pressure and microalbuminuria

21 January 2018

1 reference

Mechanisms of diabetic nephropathy

21 January 2018

1 reference

Diabetic nephropathy: hemodynamic basis and implications for disease management

21 January 2018

1 reference

Glomerular cell number in normal subjects and in type 1 diabetic patients

21 January 2018

1 reference

CD2-associated protein haploinsufficiency is linked to glomerular disease susceptibility

21 January 2018

1 reference

Diabetic nephropathy: Linking histology, cell biology, and genetics

21 January 2018

1 reference

Alternatively used promoters and distinct elements direct tissue-specific expression of nephrin.

21 January 2018

1 reference

Broadening the spectrum of diseases related to podocin mutations

21 January 2018

1 reference

Irbesartan normalises the deficiency in glomerular nephrin expression in a model of diabetes and hypertension

21 January 2018

1 reference

Modulation of nephrin in the diabetic kidney: association with systemic hypertension and increasing albuminuria

21 January 2018

1 reference

Role of nephrin in renal disease including diabetic nephropathy

21 January 2018

1 reference

Podocyte foot process broadening in experimental diabetic nephropathy: amelioration with renin-angiotensin blockade

21 January 2018

1 reference

Expression of the slit-diaphragm protein, nephrin, in experimental diabetic nephropathy: differing effects of anti-proteinuric therapies.

21 January 2018

1 reference

Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: effects of angiotensin converting enzyme inhibition

21 January 2018

1 reference

Gene expression profiling in glomeruli from human kidneys with diabetic nephropathy.

21 January 2018

1 reference

Selective impairment of gene expression and assembly of nephrin in human diabetic nephropathy

21 January 2018

1 reference

Polymorphisms in the nephrin gene and diabetic nephropathy in type 1 diabetic patients

21 January 2018

1 reference

Renal handling of albumin: a critical review of basic concepts and perspective

21 January 2018

1 reference

Earlier detection of microalbuminuria in diabetic patients using a new urinary albumin assay

21 January 2018

1 reference

The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury?

21 January 2018

1 reference

Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease.

21 January 2018

1 reference

Renoprotection: one or many therapies?

21 January 2018

1 reference

Update in podocyte biology

21 January 2018

1 reference

Gene expression profile of renal proximal tubules regulated by proteinuria

21 January 2018

1 reference

Mechanical stretch induces vascular permeability factor in human mesangial cells: mechanisms of signal transduction

21 January 2018

1 reference

The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy

21 January 2018

1 reference

The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies

21 January 2018

1 reference

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial

21 January 2018

1 reference

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

21 January 2018

1 reference

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

Diabetes and hypertension: how low should you go and with which drugs?

21 January 2018

1 reference

Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study

21 January 2018

1 reference

TGF-beta 1 as a genetic susceptibility locus for advanced diabetic nephropathy in type 1 diabetes mellitus: an investigation of multiple known DNA sequence variants

21 January 2018

1 reference

Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL.

21 January 2018

1 reference

Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy

21 January 2018

1 reference

Oral sulodexide reduces albuminuria in microalbuminuric and macroalbuminuric type 1 and type 2 diabetic patients: the Di.N.A.S. randomized trial

21 January 2018

1 reference

Effects of combination treatment with losartan and trandolapril on office and ambulatory blood pressures in non-diabetic renal disease: a COOPERATE-ABP substudy.

21 January 2018

1 reference

Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas

21 January 2018

1 reference

Diabetic nephropathy in insulin-dependent patients

21 January 2018

1 reference

Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia.

21 January 2018

1 reference

21 January 2018

Kidney and hypertension

1 reference

Renal disease and hypertension in non-insulin-dependent diabetes mellitus.

21 January 2018

1 reference

Higher blood pressure in adults with less education. Some explanations from INTERSALT

21 January 2018

1 reference

Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively

21 January 2018

1 reference

Diabetic nephropathy and antihypertensive treatment: what are the lessons from clinical trials?

21 January 2018

1 reference

Antiproteinuric versus antihypertensive effects of high-dose ACE inhibitor therapy

21 January 2018

1 reference

Clinical renoprotection trials involving angiotensin II-receptor antagonists and angiotensin-converting-enzyme inhibitors

21 January 2018

1 reference

Angiotensin-converting enzyme inhibitors and type 2 diabetic nephropathy: a meta-analysis

21 January 2018

1 reference

Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study.

21 January 2018

1 reference

Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group

21 January 2018

1 reference

Losartan and other angiotensin II antagonists for nephropathy in type 2 diabetes mellitus: a review of the clinical trial evidence

21 January 2018

1 reference

Glomerular permselectivity in early stages of overt diabetic nephropathy

21 January 2018

1 reference

Time course of the antiproteinuric and antihypertensive effect of losartan in diabetic nephropathy

21 January 2018

1 reference

Renal damage associated with proteinuria

21 January 2018

1 reference

Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial

21 January 2018

1 reference

Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on blood pressure and the kidney

21 January 2018

1 reference

A comparison of iothalamate-GFR and serum creatinine-based outcomes: acceleration in the rate of GFR decline in the African American Study of Kidney Disease and Hypertension

21 January 2018

1 reference

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

21 January 2018

1 reference

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

21 January 2018

1 reference

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

21 January 2018

1 reference

Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study

21 January 2018

1 reference

Additive effect of ACE inhibition and angiotensin II receptor blockade in type I diabetic patients with diabetic nephropathy

21 January 2018

1 reference

Combination Therapy With Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Antagonists in the Treatment of Patients With Type 2 Diabetes Mellitus

21 January 2018

1 reference

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

21 January 2018

1 reference

The verapamil versus amlodipine in nondiabetic nephropathies treated with trandolapril (VVANNTT) study

21 January 2018

1 reference

Differential effects of calcium antagonist subclasses on markers of nephropathy progression

21 January 2018

1 reference

Differential effects of calcium channel blockers on size selectivity of proteinuria in diabetic glomerulopathy

21 January 2018

1 reference

Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy

21 January 2018

1 reference

The future of clinical trials in chronic renal disease: outcome of an NIH/FDA/Physician Specialist Conference. Evaluation of Clinical Trial Endpoints in Chronic Renal Disease Study Group

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000084286

1 reference

11 August 2017

1 reference